𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Menthol-β-D-Glucuronide: A Potential Prodrug for Treatment of the Irritable Bowel Syndrome

✍ Scribed by Harold W. Nolen III; David R. Friend

Book ID
110379994
Publisher
Springer US
Year
1994
Tongue
English
Weight
878 KB
Volume
11
Category
Article
ISSN
0724-8741

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Budesonide-β-D-glucuronide: A potential
Budesonide-β-D-glucuronide: A potential prodrug for treatment of ulcerative colitis
✍ H. Nolen III; R. N. Fedorak; D. R. Frient 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 674 KB

Budesonide-beta-D-glucuronide is a potentially useful orally administered prodrug for the treatment of colonic inflammatory bowel disease. Budesonide is a topically active glucocorticosteroid that exhibits low oral bioavailability (15%) in humans and laboratory animals. Oral delivery of budesonide t

Novel serotonin type 3 receptor partial
Novel serotonin type 3 receptor partial agonists for the potential treatment of irritable bowel syndrome
✍ David D. Manning; Christopher L. Cioffi; Alexander Usyatinsky; Kevin Fitzpatrick 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 474 KB

Serotonin type 3 (5-HT(3)) receptor partial agonists are being targeted as potential new drugs for the treatment of irritable bowel syndrome (IBS). Two new chemical series bearing indazole and indole cores have exhibited nanomolar binding affinity for the h5-HT(3)A receptor. A range of partial agoni